Medical News Home

Young adults who had bipolar disorder as children are likely to suffer from manic episodes, according to an article released on October 6, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals. Bipolar disorder is a severe mood disorder that involves episodes of mania and depression.

Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc announced preliminary top-line results from a phase II clinical trial of cariprazine (RGH-188), an investigational antipsychotic, in patients with acute mania associated with bipolar I disorder.

Seroquel XL (quetiapine prolonged release) a new, once daily formulation for schizophrenia and manic episodes associated with bipolar disorder, has today become available in the UK.[1] The new formulation was developed to address the needs of patients who require effective control of symptoms in a once daily rather than twice daily tablet.

Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant drugs first line.

German researchers have devised a way to follow gene expression over time in a 64-year-old woman who developed rapid-cycling bipolar illness in her mid-40s. Over a 16-year period, the woman logged in 108 cycles in her diary. Rapid-cycling bipolar illness is characterized by four or more episodes of depression and/or mania in a given year.

Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced that following a hearing on September 12, 2008, the U.S. Court of Appeals for the District of Columbia has vacated an April 2008 ruling, which granted Teva 180-day exclusivity for its Risperidone Tablets, AB-rated to Janssen’s Risperdal® Tablets. As a result of this decision, the U.S.

In combination with medication, family-focused therapy appears to help curb depression symptoms in teens with bipolar disorder, according to a report released on September 1, 2008 in the Archives of General Psychiatry, one of the JAMA/Archives journals.  Bipolar disorders are characterized by occasional periods of elevated mood, known as mania.

Results presented at the 21st European College of Neuropsychopharmacology (ECNP) congress in Barcelona, Spain have demonstrated the efficacy of SEROQUEL® (quetiapine fumarate) monotherapy for maintenance treatment in patients with bipolar disorder.

Results from a new global survey on bipolar disorder, released today at the European College of Neuropsychopharmacology Congress, indicate that both patients and healthcare professionals face significant challenges in managing bipolar disorder. At least 90% of patients surveyed reported that the illness is difficult to understand and to live with due to the episodic symptoms.

The children of older aged fathers may have an increased risk of bipolar disorder (BPD), according to a report released on September 1, 2008 in the Archives of General Psychiatry, one of the JAMA/Archives journals. A common and intense mood disorder, people who are bipolar often experience episodes of mania and depression.